🇺🇸 FDA

Intelligence · Patent portfolio

Teva Pharma Patents

Full USPTO pharma patent portfolio for Teva Pharma — grant dates, expiration, and drug cross-links.

Patents
454
Expiring ≤24m
49

Quick answer

Teva Pharma has 454 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 49 expire within 24 months — use filters for patent-cliff planning.

Page 8 of 10

  1. US 7358247

    Mycophenolate mofetil impurity

    Expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7357945

    Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof

    Expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7355078

    Processes for the preparation of tomoxetine

    Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7348429

    Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide(zaleplon) and crystalline forms of zaleplon accessible with the process

    Expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7342120

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    Expires Mon Mar 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7335685

    Crystals of ladostigil tartrate, methods of production and pharmaceutical compositions thereof

    Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7335772

    1H-imidazo [4,5-c] quinolin-4-cyano and 1H-imidazo [4,5-c] quinolin-4-carboxamide intermediates

    Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7332612

    Amorphous and crystalline forms of losartan potassium and process for their preparation

    Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7323459

    Crystal forms, methods for their preparation and method for preparation of olanzapine

    Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7319171

    Sertraline hydrochloride form II and methods for the preparation thereof

    Expires Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7317127

    Process for the optical resolution and recycling of tomoxetine

    Expires Mon Jan 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7312340

    Synthesis of 2-butyl-3-(1-trityl-1H-tetrazol-5-YL)biphenyl-4-YL)-1,3-diazaspiro[4,4]- non-ene-4-one

    Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7301024

    Crystalline forms of gatifloxacin and processes for preparation

    Expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7294687

    Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus

    Expires Mon Nov 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7294735

    Purification of cinacalcet

    Expires Mon Nov 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7291614

    Processes for the preparation of linezolid intermediate

    Expires Mon Nov 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7279571

    Methods of preparing pimecrolimus

    Expires Mon Oct 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7276629

    Hydrogenation of imine intermediates of sertraline with catalysts

    Expires Mon Sep 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7262218

    Forms of pravastatin sodium

    Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7259261

    Racemization and enantiomer separation of clopidogrel

    Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7256195

    Preparation of risperidone

    Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7256212

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7247751

    Processes for preparing cinacalcet hydrochloride crystal Form I

    Expires Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7244844

    Reference standard for characterization of rosuvastatin

    Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7235691

    Crystalline forms of modafinil

    Expires Mon Jun 21 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7196222

    Sertraline hydrochloride form II and methods for the preparation thereof

    Expires Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7195778

    Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery

    Expires Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7192588

    Vaccine composition and method of using the same

    Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7189861

    Processes for preparing amorphous atorvastatin hemi-calcium

    Expires Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7183272

    Crystal forms of oxcarbazepine and processes for their preparation

    Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7166721

    Preparation of 1H-imidazo[4,5-C] quinolin 4-amines via novel 1H-imidazo[4,5-c] quinolin 4-cyano and 1H-imidazo[4,5-c] quinolin 4-carboxamide intermediates

    Expires Mon Jan 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7161012

    Processes for preparing amorphous atorvastatin hemi-calcium

    Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7153967

    Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via 1H-imidazo [4,5-C] quinolin-4-phthalimide intermediates

    Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7151183

    Processes for preparing amorphous atorvastatin hemi-calcium

    Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7148376

    Polymorphic forms of nateglinide

    Expires Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7144916

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    Expires Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7138137

    Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof

    Expires Mon Nov 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7129358

    Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazoles

    Expires Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7126008

    Carvedilol

    Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7122681

    Desolvation process for the production of atorvastatin hemi-calcium essentially free of bound organic solvent

    Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7098345

    Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-YL)methyl]-4H-carbazol-4-one

    Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7078223

    Process for the preparation of pseudomonic acid a antibiotic by microbiological method

    Expires Mon Jul 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7060837

    Method for the purification of lansoprazole

    Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7056942

    Carvedilol

    Expires Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7038060

    Synthesis of 2-butyl-3-(2′-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspiro[4.4]-non-ene-4-one

    Expires Mon Apr 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  46. US 7033582

    Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders

    Expires Mon Apr 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  47. US 7022881

    Sertraline hydrochloride polymorphs

    Expires Mon Mar 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  48. US 7022859

    Method for the purification of lansoprazole

    Expires Mon Mar 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Teva Pharma have?

454 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Teva Pharma patents expire?

49 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.